CPR Invest - Global Equity - R EUR (C) ISIN : LU1811426938
Marketing Communication
NAVs
Performance
All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.
Past performance does not guarantee future returns. The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.
The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).
The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.
All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.
Past performance does not guarantee future returns. The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.
The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).
The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.
Portfolio Analysis
Management commentary
Markets were awaiting all the new U.S. releases, trying to anticipate the next move of the FED. Slowly, certainty shifted towards 50 basis points and this was the last move of the FED. Moreover, China's stimulus measures sparked renewed optimism about Asia, ignoring the extreme geopolitical tensions in the Middle East and Ukraine.
China thus performed excellently, with 17.6% for the Shanghai Composite and 18.3% for the Hang Seng, leading the emerging markets (+6.7%). The United States had another good month, helped by the FED's cut with a gain of 2.1% for the S&P and 2.8% for the Nasdaq, but with greater diversity in Europe: the United Kingdom lost 1.5%, Italy 0.6% while Spain gained 4.3% and Germany 2.2%. Japan, impacted by political uncertainty and rates, lost 1.3% during a very volatile month.
Commodities were also very volatile: oil lost 8%, but agriculture and metallurgy made gains (sugar 17%, corn 12.4% and wheat 9.6%, silver 8%, copper 9.8% and gold reached a new peak after a rise of 5.2%).
In September, Japanese stocks began to fall sharply due to the slowdown in the American economy, increasing market mistrust before the start of the Fed's rate cut cycle and the yen appreciation cycle. However, after the FOMC and BoJ meetings, Japanese stocks rebounded thanks to the improvement in the outlook for the American economy due to a preventive 50 bp rate cut by the Fed and the easing of concerns about yen appreciation. Subsequently, the end of the month was marked by high volatility in exchange rates and the stock market due to uncertainty about the political situation before the PLD presidential election on September 27 and a cautious sentiment towards the policies of the hardline factions after Ishiba's election to the presidency. As confirmed at a press conference on October 1, the Ishiba administration turned to an accommodative fiscal stance rather than the belligerent one initially feared.
Review of the Main Positions of the Month
Over the month, the fund's performance was behind that of the benchmark index.
We note a neutral sector effect, with good selection in the Consumer Goods and Materials - Chemistry sectors but negative in the Materials - Other and Industrial - Machinery sectors.
The country effect was neutral, with a good contribution in Europe and North America but negative in Japan and Emerging Markets.
We also observed a negative effect of our aggressive factor, with a contribution of around -0.44%, and at the same time note a negative effect of our defensive factor showing a contribution of -1.02%.
The capitalization size effect was negligible.
During the period under review, we were overweight on the quality factor and underweight on the earnings momentum factor.
At the stock level, we find very good contributors to performance such as NetEase Inc (OW, 20.2%), Yum China Holdings, (OW, 32.1%), Oracle (UW, 19.6%), NetEase (ADR). On the contrary, the following values penalized us: Tesla (UW, 21%), ASML (OW, -8%), KLA (OW, -6%), Stellantis (OW, -17%).
Here are the main operations carried out over the period: we bought Linde PLC / Yum! Brands/Trane Technologies and sold Dollarama Inc./Citigroup /Broadcom.
These led to a decrease in the weight of the Quality factor and an increase in the Defensive factor.
Outlook for the Following Month
An unusually large divergence between growth momentum indicators has emerged this quarter. These tensions may suggest that global expansion will slow to a pace below trend over the next two quarters. However, these developments also widen the extreme risks around this baseline. Unless there is a pause, fears of a slowdown in labor demand in developed markets and the decline in global manufacturing surveys keep the risk of a short-term recession high.
The last factor to emerge at the end of the quarter was the significant announcements of stimulus measures by China, leading to a surge in Chinese stocks and more broadly in stocks exposed to China.
This factor is to be monitored as it could cause capital outflows and reallocation from Japan to China.
However, we expect a normalization of operations towards China and after the sales on Japan due to the election of Mr. Ishiba. He confirmed the holding of a general election at the end of October. Welcomed by a rebound of the yen, this result should ensure continuity in Japanese policy and allow the BoJ to maintain room for maneuver. S. Ishiba reaffirmed his commitment to fully emerge Japan from deflation and argued in favor of continuing wage increases and support for consumption.
Characteristics
General data
Costs Composition
| One-off costs upon entry or exit (Investment EUR 10,000) | If you exit after 1 year | ||
| Entry costs | This includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge. | Up to €500.00 | |
| Exit costs | We do not charge an exit fee for this product, but the person selling you the product may do so. | €0.00 | |
| Ongoing costs taken each year (Investment EUR 10,000) | |||
| Management fees and other administrative or operating costs | 1.24% of the value of your investment per year. This percentage is based on actual costs over the last year. | €117.80 | |
| Transaction costs | 0.41% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell. | €38.65 | |
| Incidental costs taken under specific conditions (Investment EUR 10,000) | |||
| Performance fees | 20.00% annual outperformance of the reference asset 20% of the difference between the net assets of the Share Class and the Reference Asset. Performance indicator : MSCI All Countries World Net Return index. ESMA methodology since 01/01/2022. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years. The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset. | €0.00 | |
Codification
Investment Objective
Documents
| Language | Documents | Type | Closing Date |
|---|---|---|---|
NL | PDF | 18/12/2025 | |
PDF | 31/01/2026 | ||
EN | PDF | 31/07/2025 | |
PDF | 07/05/2026 |
Sustainability-related disclosures
| Language | Documents | Type | Closing Date |
|---|---|---|---|
NL | PDF | 18/12/2025 | |
EN | PDF | 07/05/2026 |
Nothing contained in this site constitutes a solicitation or offer by any member of the Amundi to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". Amundi does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.
The collective inestment scheme (UCITS) has been recognised for public marketing in the Netherlands by the Authority for The Financial Markets (AFM)